EValuation of Acute and Early Phase P2Y12 Inhibitor DE-escalation After PerCutaneous Intervention (EVADE PCI).

Kans J Med · 2025 · PMC12135783 · PMID 40476260

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Compared to unchanged DAPT, the de-escalation group showed a trend toward lower all-cause mortality and major bleeding.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.